The Department of Defense is seeking quotes for pharmaceutical agents in specific drug classes for potential inclusion in its Uniform Formulary. The services relate to the review of Antihemophilic Agents and Leukemia/Lymphoma treatments scheduled for a committee meeting in MAY 2026. A pre-quotation teleconference is scheduled for February 11, 2026. The resulting agreements may be used to award Blanket Purchase Agreements and Additional Discount Program Agreements. The performance location is not specified, and no budget information is provided.

The Department of Defense is seeking quotes for pharmaceutical agents in specific drug classes for potential inclusion on its Uniform Formulary. The services relate to the review of Antihemophilic Agents and Leukemia/Lymphoma treatments scheduled for a committee meeting in MAY 2026. A pre-quotation teleconference is scheduled for February 11, 2026. The resulting agreements may be used to award Blanket Purchase Agreements and Additional Discount Program Agreements. The performance location is not specified, and no budget amounts are listed.